Other
Craving
0
Pipeline Programs↗
0
Active Trials↗
1
Companies Involved↗
Craving is an early-stage landscape with 0 programs across 1 company. The most active players are GSK.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
27
clinical trials
Completed22 · 81%
Terminated2 · 7%
Unknown status2 · 7%
Withdrawn1 · 4%
Clinical Trials
Trial Activity
27 trials
Effects of Nicotine Replacement and Repeated Cue Exposure on Cigarette Craving
Completed·—·Phase 1·NCT01329614·40 enrolled
Cannabidiol and Cocaine Craving/Dependence
Completed·—·Phase 2·NCT02559167·79 enrolled
Endocannabinoids, Stress, Craving And Pain Effects Study
Completed·—·Phase 1·NCT05480072·12 enrolled
Acute and Short-term Effects of CBD on Cue-induced Craving in Drug-abstinent Heroin-dependent Humans
Completed·—·Phase 2·NCT02539823·45 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)